286 related articles for article (PubMed ID: 3522737)
1. Role of self carriers in the immune response and tolerance. X. A lymphoid dendritic-like tumor, P388AD.2, acts as a novel immunogenic carrier for hapten.
Cogswell JP; Phipps RP; Scott DW
J Immunol; 1986 Aug; 137(3):777-83. PubMed ID: 3522737
[TBL] [Abstract][Full Text] [Related]
2. Conversion of a tolerogenic to an immunogenic signal by P388AD.2 cells, a lymphoid dendritic cell-like tumor line.
Phipps RP; Pillai PS; Scott DW
J Immunol; 1984 May; 132(5):2273-8. PubMed ID: 6201539
[TBL] [Abstract][Full Text] [Related]
3. Immunogenic presentation of an immunoglobulin "tolerogen" requires interleukin 2.
Sadegh-Nasseri S; Phipps RP
Eur J Immunol; 1988 Mar; 18(3):417-23. PubMed ID: 2451614
[TBL] [Abstract][Full Text] [Related]
4. Two signals are required for accessory cells to induce B cell unresponsiveness. Tolerogenic Ig and prostaglandin.
Schad VC; Phipps RP
J Immunol; 1988 Jul; 141(1):79-84. PubMed ID: 2454266
[TBL] [Abstract][Full Text] [Related]
5. Role of the major histocompatibility complex in T cell activation of B cell subpopulations: antigen-specific and H-2-restricted monoclonal TH cells activate Lyb-5+ B cells through an antigen-nonspecific and H-2-unrestricted effector pathway.
Hodes RJ; Shigeta M; Hathcock KS; Fathman CG; Singer A
J Immunol; 1982 Jul; 129(1):267-71. PubMed ID: 6177752
[TBL] [Abstract][Full Text] [Related]
6. Role of self-carriers in the immune response and tolerance. II. Parameters of tolerance induced by haptenated lymphoid cells.
Long CA; Scott DW
Eur J Immunol; 1977 Jan; 7(1):1-6. PubMed ID: 300326
[TBL] [Abstract][Full Text] [Related]
7. Functional differentiation in the genetic control of murine T lymphocyte responses to human fibrinopeptide B.
Peterson LB; Wilner GD; Thomas DW
J Immunol; 1983 Feb; 130(2):637-43. PubMed ID: 6217245
[TBL] [Abstract][Full Text] [Related]
8. A novel role for macrophages: the ability of macrophages to tolerize B cells.
Phipps RP; Scott DW
J Immunol; 1983 Nov; 131(5):2122-7. PubMed ID: 6195250
[TBL] [Abstract][Full Text] [Related]
9. Role of self carriers in the immune response and tolerance. IV. Active T cell suppression in the maintenance of B cell tolerance to a "T-independent" antigen.
Jandinski JJ; Scott DW
J Immunol; 1979 Dec; 123(6):2447-50. PubMed ID: 315422
[TBL] [Abstract][Full Text] [Related]
10. Sodium periodate-induced T cell mitogenesis: an analysis of the requirement for Ia and IL 1.
Smith LA; Cohen DA; Lachman LB; Kaplan AM
J Immunol; 1985 Aug; 135(2):1137-44. PubMed ID: 2989361
[TBL] [Abstract][Full Text] [Related]
11. Differential presentation of tolerogenic immunoglobulin in vivo by macrophages and by a lymphoid dendritic cell-like tumor line.
Phipps RP; Illig K; Schad V; Bhimani K
J Leukoc Biol; 1988 Mar; 43(3):271-8. PubMed ID: 3257790
[TBL] [Abstract][Full Text] [Related]
12. Role of self carriers in the immune response and tolerance. XII. Effect of epitope density and antigen-presenting cell phenotype on the presentation of hapten-modified self for the induction of immunity or tolerance in vitro.
Cogswell JP; Scott DW
Cell Immunol; 1988 Jun; 114(1):71-82. PubMed ID: 2453295
[TBL] [Abstract][Full Text] [Related]
13. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). V. T cell proliferative response and cellular interactions.
Milich DR; Louie RE; Chisari FV
J Immunol; 1985 Jun; 134(6):4194-202. PubMed ID: 3921619
[TBL] [Abstract][Full Text] [Related]
14. The role of B cell surface Ia antigen recognition by T cells in B cell triggering. Analysis of the interaction of cloned helper T cells with normal B cells in differing states of activation and with B cells expressing the xid defect.
Tite JP; Kaye J; Jones B
Eur J Immunol; 1984 Jun; 14(6):553-61. PubMed ID: 6376147
[TBL] [Abstract][Full Text] [Related]
15. Role of self carriers in the immune response and tolerance. XI. Correlation of Ia expression and interleukin-1 production with delivery of immunogenic signals in vivo by hapten-modified accessory cell-like tumor lines.
Cogswell JP; Phipps RP; Scott DW
Cell Immunol; 1988 Jun; 114(1):55-70. PubMed ID: 3259475
[TBL] [Abstract][Full Text] [Related]
16. Lyb-5+ B cells can be activated by major histocompatibility complex-restricted as well as unrestricted activation pathways.
Asano Y; Singer A; Hodes RJ
J Immunol; 1985 Jun; 134(6):3682-5. PubMed ID: 3872901
[TBL] [Abstract][Full Text] [Related]
17. Suppression of anti-hapten antibody responses by hapten-specific cytolytic T lymphocytes: role of I-A-associated antigen on target B lymphocytes.
Moser G; Burakoff SJ; Abbas AK
J Immunol; 1982 Jul; 129(1):63-9. PubMed ID: 6177761
[TBL] [Abstract][Full Text] [Related]
18. The induction of hapten-specific T cell tolerance by using hapten-modified lymphoid cells. I. Characteristics of tolerance induction.
Miller SD; Claman HN
J Immunol; 1976 Nov; 117(5 Pt 1):1519-26. PubMed ID: 1087316
[TBL] [Abstract][Full Text] [Related]
19. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
20. Effects of hapten epitope structure and hapten-self conjugation pattern on T cell specificity and Ir gene control in hapten-self cytotoxic and helper T cell responses.
Takai Y; Mizuochi T; Fujiwara H; Hamaoka T
J Immunol; 1984 Jan; 132(1):57-62. PubMed ID: 6197460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
